-
May 21, 2010
When Forest Labs' management realizes that its shares are cheap, the best use of the balance will be to buy back the ...
-
May 10, 2010
Should investors hang on despite a devastating FDA decision?
-
April 30, 2010
Glaxo's earnings look powerful, but is this really a top idea in the pharma sector?
-
April 30, 2010
Amid all of the furor over healthcare reform, WellPoint leveraged a tough environment into another strong quarter.
-
April 23, 2010
These healthcare and pharma companies have a solid dividend and increasing earnings over the last five years.
-
April 16, 2010
Look beyond the trees and at the entire Forest, and what you see is a great risk reward opportunity.
-
March 03, 2010
Protection is the name of the game, and these options can help shield you from a volatile European Union.
-
February 04, 2010
Investors are worried about Lipitor's patent running out, but Pfizer has many other ways to give your portfolio a rise.
-
January 13, 2010
Looking across the pond at the UK, one can't help but be attracted to some of the opportunities.
-
December 09, 2009
Investors lost interest in swine flu vaccine stocks, like AZN and GSK, before they had a chance to enjoy any revenue.
-
October 29, 2009
Investors should keep a close watch on drug distribution firm McKesson's stock.
-
October 28, 2009
A look at some of the best-performing stocks year to date - up anywhere from 400% to 2000%.
-
October 02, 2009
Flu vaccine shares still have long-term appeal.
-
August 25, 2009
Merck regaining its swagger, after a steady decline last year.
-
July 28, 2009
A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than ...
-
July 28, 2009
Although Baxter shares have been cheaper, at it's current valuation, this stock might still be just what the doctor ...
-
July 20, 2009
The swine flu vaccine race appears to have multiple winners.
-
April 24, 2009
A look at recent merger and acquisition activity in the pharmaceutical sector and possible opportunities if the ...
-
April 03, 2009
Abbott Labs has continued to perform solidly as a business and looks poised with its product line to keep going strong.
-
March 26, 2009
Even with declining sales, Whirlpool has the stock prices and dividend yields that make it a company of interest.
